1AD
Click for more information
4.00% 2.6¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-13

  1. 64palms
    373 Posts.
    lightbulb Created with Sketch. 186
    clock Created with Sketch.
    08/04/24
    12:10
    Post #: 73237749
    You always say this but the time decay/risk is a factor.


    Great Ann otherwise.

    finding innovative ways to accelerate work programs and get funding.

    1AD Price at posting: 3.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.6¢ 		Change
0.001(4.00%) 		Mkt cap ! $15.48M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $2.302K 90.63K

Buyers (Bids)

No. Vol. Price($)
1 158374 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 437561 2
View Market Depth
Last trade - 15.26pm 28/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.